Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2025	Mar. 31, 2024	Mar. 31, 2025	Mar. 31, 2024	Jun. 30, 2024
Statement of Cash Flows [Abstract]
Net Loss			$ (6,221,934)	$ (5,462,764)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation			2,081	1,020
Stock based compensation			524,692	259,325
Amortization of debt issuance costs			130,516	48,368
Non-cash interest expense			1,141,668	584,902
Accretion expense	$ 45,619	$ 110,558	179,794	331,676	$ 442,234
Settlement of asset retirement obligations			(90,000)	(90,000)
Change in derivative liability	11,874	278,556	175,929	278,556
Effect of changes in operating working capital items:
Change in prepaid expenses			615,629	696,615
Change in accounts payable			(22,384)	287,488
Cash used in operating activities			(3,564,009)	(3,064,814)
Cash flows from investing activities:
Purchase of mineral properties			(150,000)	(100,000)
Purchase of equipment			(9,098)
Cash used in investing activities			(159,098)	(100,000)
Cash flows from financing activities:
Capital issued for financing, net of share issuance costs			439,564	1,167,893
Proceeds from royalty convertible debenture				15,000,000
Royalty convertible debenture issuance costs				(870,111)
Repayment of 2019 convertible notes				(4,277,690)
Repayment of notes payable, related parties				(1,667,833)
Cash provided by financing activities			439,564	9,352,259
Change in cash during period			(3,283,543)	6,187,445
Cash at beginning of period			5,423,059	824,920	824,920
Cash at end of period	$ 2,139,516	$ 7,012,365	$ 2,139,516	$ 7,012,365	$ 5,423,059